Case Report
Fixed Apparatus Medication of a Skeletal Class II Open Chomp Malocclusion with Hypomature Amelogenesis Blemished: Case Report
Halimi A1*, El alloussi M2, Sefiani A3and Zaoui F1 | |
1University Mohammed V-Souissi (UM5S), Faculty of Dentistry,BiotechResearch Team. MMB, IbnSinaHospital, Centre for DentalConsultationand Treatment, Department of Orthodontics and dentofacial Orthopedics, Israel | |
2University Mohammed V-Souissi (UM5S), Faculty of Dentistry Rabat Ibn Sina Hospital, Centre for Dental Consultation and Treatment, Department of Pediatric dentistry, Israel | |
3University Mohammed V-Souissi (UM5S), genomic center of humain science, Department of medical genetic, Israel | |
Corresponding Author : | Abdelali Halimi Specialist qualified in orthodontics University Mohammed V-Souissi (UM5S) Rabat Faculty of Dentistry, Research Team of Biotech. MMB Ibn Sina Hospital, Department of Orthodontics and Dentofacial Orthopedics, Rabat City, Morocco Tel: +212666285639, 0021237790844 E-mail: halimiali111@yahoo.fr |
Received April 09, 2013; Accepted May 03, 2013; Published May 05, 2013 | |
Citation: Halimi A, El alloussi M, Sefiani A, Zaoui F (2013) Fixed Apparatus Medication of a Skeletal Class II Open Chomp Malocclusion with Hypomature Amelogenesis Blemished: Case Report. J Nov Physiother 3:137. doi: 10.4172/2165-7025.1000137 | |
Copyright: © 2013 Halimi A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
Abstract
This article depicts the orthodontic medicine of a 12-year-old female tolerant having askeletal Class II malocclusion with localised hypomature amelogenesisimperfecta. We were fit to fulfil orthodontic medication without causingdental polish harm for example demineralization, white spot sore and breaks when were moved the edgewise apparatuses. A great impediment and feel grins were realized, and these comes about have been administered for three years after fruition of the animated medication.